Sherbrooke Park Advisers LLC Ptc Therapeutics, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q1 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 5,382 shares of PTCT stock, worth $252,738. This represents 0.13% of its overall portfolio holdings.
Number of Shares
5,382Holding current value
$252,738% of portfolio
0.13%Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
283Shares Held
78.5MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$404 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$365 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$351 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$255 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$254 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.36B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...